The World Bank. Data: South Africa. 2023. Available from: https://data.worldbank.org/country/south-africa. Accessed 14 Jul 2023.

The World Bank. Gini index - South Africa. 2019. Available from: https://data.worldbank.org/indicator/SI.POV.GINI?locations=ZA. Accessed 3 May 2023.

Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817–34. https://doi.org/10.1016/S0140-6736(09)60951-X.

Article  PubMed  Google Scholar 

Statistics South Africa. General Household Survey, 2019. Pretoria; 2020. Available from: www.statssa.gov.za/publications/P0318/P03182019.pdf. Accessed 1 Sep 2023.

Anand S, Bajpai M, Goel P. Pediatric infections in the intensive care unit (ICU). In: Infectious Diseases in the Intensive Care Unit. Singapore: Springer; 2020. p. 349–63.

Kannan A, Pratyusha K, Thakur R, Sahoo MR, Jindal A. Infections in critically ill children. Indian J Pediatr. 2023;90(3):289–97. https://doi.org/10.1007/s12098-022-04420-9.

Article  PubMed  Google Scholar 

Brusselaers N, Vogelaers D, Blot S. The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care. 2011;1:47. https://doi.org/10.1186/2110-5820-1-47.

Article  PubMed  PubMed Central  Google Scholar 

Exner M, Bhattacharya S, Christiansen B, Gebel J, Goroncy-Bermes P, Hartemann P, et al. Antibiotic resistance: what is so special about multidrug-resistant Gram-negative bacteria? GMS Hyg Infect Control. 2017;12(Doc05):1–24. https://doi.org/10.3205/dgkh000290.

Article  Google Scholar 

•• Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55. https://doi.org/10.1016/S0140-6736(21)02724-0. Mostcomprehensiveoverviewofglobalburdenofantimicrobialresistance.

Article  CAS  Google Scholar 

Review on Antimicrobial Resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. London; 2014. Available from: https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf. Accessed 9 Jul 2023.

Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. London; 2016. Available from: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf. Accessed 9 Jul 2023.

•• Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America antimicrobial-resistant treatment guidance: Gram-negative bacterial infections. 2023. Available from: www.idsociety.org/practice-guideline/amr-guidance/. Accessed 19 Jul 2023. Most recent American guidelines for treatment of multidrug-resistant Gram-negative organisms.

Vilar-Compte D, Camacho-Ortiz A, Ponce-de-León S. Infection control in limited resources countries: challenges and priorities. Curr Infect Dis Rep. 2017;19(5):20. https://doi.org/10.1007/s11908-017-0572-y.

Article  PubMed  Google Scholar 

World Health Organization. Report on the burden of endemic health care-associated infection worldwide. Geneva; 2011. Available from: https://apps.who.int/iris/bitstream/10665/80135/1/9789241501507_eng.pdf. Accessed 31 Aug 2023.

• Maki G, Zervos M. Health care–acquired infections in low- and middle-income countries and the role of infection prevention and control. Infect Dis Clin North Am. 2021;35(3):827–39. https://doi.org/10.1016/j.idc.2021.04.014. Comprehensive review of infection prevention and control measures in LMICs.

Forde CA, Martindale Y, Patel S. The real scenario in infection prevention and control in low- and middle-income countries: the challenge of “starting from scratch.” Curr Treat Options Infect Dis. 2019;11(3):281–91. https://doi.org/10.1007/s40506-019-00196-3.

Article  Google Scholar 

Iskandar K, Molinier L, Hallit S, Sartelli M, Hardcastle TC, Haque M, et al. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control. 2021;10(1):63. https://doi.org/10.1186/s13756-021-00931-w.

Article  PubMed  PubMed Central  Google Scholar 

Labib JR, Ibrahim SK, Salem MR, Youssef MRL, Meligy B. Infection with gram-negative bacteria among children in a tertiary pediatric hospital in Egypt. Am J Infect Control. 2018;46(7):798–801. https://doi.org/10.1016/j.ajic.2017.12.008.

Article  PubMed  Google Scholar 

Thatrimontrichai A, Premprat N, Janjindamai W, Dissaneevate S, Maneenil G. Multidrug-resistant Gram-negative bacilli sepsis from a neonatal intensive care unit: a case-case-control study. J Infect Dev Ctries. 2019;13(7):603–11. https://doi.org/10.3855/jidc.10402.

Article  CAS  PubMed  Google Scholar 

Uc-Cachón AH, Gracida-Osorno C, Luna-Chi IG, Jiménez-Guillermo JG, Molina-Salinas GM. High prevalence of antimicrobial resistance among Gram-negative isolated bacilli in intensive care units at a tertiary-care hospital in Yucatán Mexico. Medicina. 2019;55(9):588. https://doi.org/10.3390/medicina55090588.

Article  PubMed  PubMed Central  Google Scholar 

Ballot DE, Nana T, Sriruttan C, Cooper PA. Bacterial bloodstream infections in neonates in a developing country. ISRN Pediatr. 2012;2012:1–6. https://doi.org/10.5402/2012/508512.

Article  Google Scholar 

Gandra S, Tseng KK, Arora A, Bhowmik B, Robinson ML, Panigrahi B, et al. The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study. Clin Infect Dis. 2019;69(4):563–70. https://doi.org/10.1093/cid/ciy955.

Article  PubMed  Google Scholar 

Vandresen D, Werlang MHB, Silva MCB, Link JS, N. Fortes PC. Community origin and previous use of antimicrobials increase the risk of nosocomial multidrug-resistant bacteria colonisation in the intensive care unit in a Brazilian hospital. Open Public Health J. 2019;12(1):449–54. https://doi.org/10.2174/1874944501912010449.

Golli AL, Cristea OM, Zlatian O, Glodeanu AD, Balasoiu AT, Ionescu M, et al. Prevalence of multidrug-resistant pathogens causing bloodstream infections in an intensive care unit. Infect Drug Resist. 2022;15:5981–92. https://doi.org/10.2147/IDR.S383285.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, Yu F, Yu Y, Zhang Y, Jiang Y. Clinical significance of MDRO screening and infection risk factor analysis in the ICU. Am J Transl Res. 2021;13(4):3717–23.

CAS  PubMed  PubMed Central  Google Scholar 

Siwakoti S, Subedi A, Sharma A, Baral R, Bhattarai NR, Khanal B. Incidence and outcomes of multidrug-resistant Gram-negative bacteria infections in intensive care unit from Nepal - a prospective cohort study. Antimicrob Resist Infect Control. 2018;7:114. https://doi.org/10.1186/s13756-018-0404-3.

Article  PubMed  PubMed Central  Google Scholar 

Lochan H, Pillay V, Bamford C, Nuttall J, Eley B. Bloodstream infections at a tertiary level paediatric hospital in South Africa. BMC Infect Dis. 2017;17:750. https://doi.org/10.1186/s12879-017-2862-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dramowski A, Cotton MF, Rabie H, Whitelaw A. Trends in paediatric bloodstream infections at a South African referral hospital. BMC Pediatr. 2015;15:33. https://doi.org/10.1186/s12887-015-0354-3.

Article  PubMed  PubMed Central  Google Scholar 

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66. https://doi.org/10.1016/S1473-3099(18)30605-4.

Article  PubMed  PubMed Central  Google Scholar 

National Institute for Communicable Diseases. GERMS-SA Annual Report 2019. 2019. Available from: https://www.nicd.ac.za/wp-content/uploads/2021/02/GERMS-Annual-Review-2019_.pdf. Accessed 29 Mar 2023.

Olowo-Okere A, Yacouba A. Molecular mechanisms of colistin resistance in Africa: a systematic review of literature. Germs. 2020;10(4):367–79. https://doi.org/10.18683/germs.2020.1229

Venne DM, Hartley DM, Malchione MD, Koch M, Britto AY, Goodman JL. Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa. Antimicrob Resist Infect Control. 2023;12:29. https://doi.org/10.1186/s13756-023-01220-4.

Khan ZA, Siddiqui MF, Park S. Current and emerging methods of antibiotic susceptibility testing. Diagnostics. 2019;9(2):49. https://doi.org/10.3390/diagnostics9020049.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gajic I, Kabic J, Kekic D, Jovicevic M, Milenkovic M, Mitic Culafic D, et al. Antimicrobial susceptibility testing: a comprehensive review of currently used methods. Antibiotics. 2022;11(4):427. https://doi.org/10.3390/antibiotics11040427.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ombelet S, Ronat JB, Walsh T, Yansouni CP, Cox J, Vlieghe E, et al. Clinical bacteriology in low-resource settings: today’s solutions. Lancet Infect Dis. 2018;18(8):e248–58. https://doi.org/10.1016/S1473-3099(18)30093-8.

Article  PubMed  Google Scholar 

Ayfan AK, Macdonald J, Harris PN, Heney C, Paterson DL, Trembizki E, et al. Rapid detection of NDM and VIM carbapenemase encoding genes by recombinase polymerase amplification and lateral flow-based detection. Eur J Clin Microbiol Infect Dis. 2021;40:2447–53. https://doi.org/10.1007/s10096-021-04267-6.

Article  CAS  PubMed  Google Scholar 

Jacobs J, Hardy L, Semret M, Lunguya O, Phe T, Affolabi D, et al. Diagnostic bacteriology in district hospitals in sub-Saharan Africa: at the forefront of the containment of antimicrobial resistance. Front Med. 2019;6:205. https://doi.org/10.3389/fmed.2019.00205.

Article  Google Scholar 

Dailey PJ, Osborn J, Ashley EA, Baron EJ, Dance DAB, Fusco D, et al. Defining system requirements for simplified blood culture to enable widespread use in resource-limited settings. Diagnostics. 2019;9:10. https://doi.org/10.3390/diagnostics9010010.

Article  PubMed  PubMed Central  Google Scholar 

Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis. 2006;42(3):377–82. https://doi.org/10.1086/499363.

Article  PubMed  Google Scholar 

Jonasson E, Matuschek E, Kahlmeter G. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother. 2020;75(4):968–78. https://doi.org/10.1093/jac/dkz548.

Article  CAS  PubMed  PubMed Central  Google Scholar 

The European Committee on Antimicrobial Susceptibility Testing. Zone diameter breakpoint tables for rapid antimicrobial susceptibility testing (RAST) directly from blood culture bottles. Version 6.1; 2023. Available from: http://www.eucast.org. Accessed 13 Jul 2023.

Brink AJ, Coetzee J, Richards GA, Feldman C, Lowman W, Tootla HD, et al. Best practices: appropriate use of the new β-lactam/β-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa. S Afr J Infect Dis. 2022;37(1): a453. https://doi.org/10.4102/sajid.v37i1.453.

Article  Google Scholar 

•• Paul M, Carrara E, Retamar P, Tängdén T, Bitterman R, Bonomo RA, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28(4):521–47. https://doi.org/10.1016/j.cmi.2021.11.025. Most recent European guidelines for treatment of multidrug-resistant Gram-negative organisms.

Article  CAS  PubMed